Skip to main content
. 2016 May 13;2016(5):CD012183. doi: 10.1002/14651858.CD012183
Withdrawals (Analysis‐4): Odds Ratios, Risk Ratios and Risk Difference for All Treatment Comparisons‐Random Effects Model
Treatment Reference OR (95% CrI) RR (95% CrI) RD % (95% Crl)
SD PL 1.32 (1.00,1.80) 1.31 (1.00,1.76) 0.01 (0.00,0.02)
HD   1.23 (0.83,1.84) 1.22 (0.84,1.80) 0.01 (0.00,0.02)
LD   0.94 (0.61,1.44) 0.94 (0.62,1.43) 0.00 (‐0.01,0.01)
MTXSD   1.19 (0.98,1.47) 1.19 (0.98,1.45) 0.00 (0.00,0.01)
MTXHD   1.48 (1.08,2.04) 1.47 (1.08,1.99) 0.01 (0.00,0.03)
MTXLD   1.13 (0.69,1.87) 1.13 (0.70,1.83) 0.00 (‐0.01,0.02)
HD SD 0.93 (0.59,1.43) 0.94 (0.60,1.41) 0.00 (‐0.02,0.01)
LD   0.71 (0.46,1.07) 0.71 (0.47,1.07) ‐0.01 (‐0.02,0.00)
MTXSD   0.90 (0.66,1.21) 0.90 (0.67,1.20) 0.00 (‐0.01,0.01)
MTXHD   1.13 (0.74,1.65) 1.12 (0.75,1.62) 0.00 (‐0.01,0.02)
MTXLD   0.86 (0.49,1.48) 0.86 (0.50,1.46) 0.00 (‐0.02,0.01)
LD HD 0.76 (0.45,1.30) 0.76 (0.46,1.29) ‐0.01 (‐0.02,0.01)
MTXSD   0.97 (0.63,1.48) 0.97 (0.64,1.46) 0.00 (‐0.02,0.01)
MTXHD   1.20 (0.75,1.90) 1.20 (0.76,1.86) 0.01 (‐0.01,0.02)
MTXLD   0.92 (0.50,1.70) 0.92 (0.51,1.68) 0.00 (‐0.02,0.02)
MTXSD LD 1.27 (0.81,1.98) 1.27 (0.82,1.95) 0.01 (‐0.01,0.02)
MTXHD   1.58 (0.96,2.61) 1.56 (0.96,2.54) 0.01 (0.00,0.03)
MTXLD   1.22 (0.65,2.29) 1.21 (0.65,2.24) 0.00 (‐0.01,0.02)
MTXHD MTXSD 1.25 (0.89,1.72) 1.24 (0.90,1.69) 0.01 (0.00,0.02)
MTXLD   0.95 (0.58,1.56) 0.95 (0.59,1.53) 0.00 (‐0.01,0.02)
MTXLD MTXHD 0.77 (0.44,1.34) 0.77 (0.45,1.33) ‐0.01 (‐0.03,0.01)
         
Random‐Effect Model Residual Deviance 155.8 vs 158 data points
  Deviance Information Criteria 764.003
Fixed‐Effect Model Residual Deviance 179.6 vs 158 data points
  Deviance Information Criteria 771.113
Note:        
         
Total Patients 24137      
Total Studies 62      
2‐arm 38      
3‐arm 17      
4‐arm 6      
7‐arm 1